TRACON Pharmaceuticals (TCON) News Today $0.08 0.00 (0.00%) (As of 10/10/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated by Analysts at StockNews.comOctober 5, 2024 | americanbankingnews.comTRACON Pharma (OTC:TCON) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comTRACON Pharmaceuticals Announces it Will Wind Down OperationsJuly 30, 2024 | globenewswire.comTRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma PatientsJune 11, 2024 | globenewswire.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q1 2024 Earnings Call TranscriptMay 15, 2024 | msn.comQ1 2024 TRACON Pharmaceuticals Inc Earnings CallMay 15, 2024 | finance.yahoo.comTRACON Pharmaceuticals Inc (TCON) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 15, 2024 | finance.yahoo.comTCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024May 14, 2024 | investorplace.comTRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | finance.yahoo.comTRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | globenewswire.comTRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024May 7, 2024 | globenewswire.comTRACON Pharmaceuticals IncApril 26, 2024 | money.usnews.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Sees Significant Drop in Short InterestTRACON Pharmaceuticals, Inc. (NASDAQ:TCON - Get Free Report) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 744,900 shares, a drop of 60.8% from the March 15th total of 1,900,000 shares. Based on an average daily volume of 3,400,000 shares, the short-interest ratio is presently 0.2 days.April 11, 2024 | marketbeat.comBuy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation UpdateApril 10, 2024 | markets.businessinsider.comTRACON announces 1-for-20 reverse stock splitApril 10, 2024 | uk.investing.comWall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024April 10, 2024 | investorplace.comTrading was temporarily halted for "TCON" at 07:04 PM with a stated reason of "News pending."April 10, 2024 | marketbeat.comShares of Tracon Pharmaceuticals Tumble 22% on Reverse SplitApril 8, 2024 | marketwatch.comTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock SplitApril 8, 2024 | finanznachrichten.deTRACON Pharmaceuticals Announces Reverse Stock SplitApril 8, 2024 | globenewswire.comBuy Rating Affirmed for TRACON Pharmaceuticals Amid Promising Envafolimab Trial OutlookApril 4, 2024 | markets.businessinsider.comTracon Pharma drops after pivotal data for cancer drugApril 3, 2024 | msn.comTRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as PlannedApril 3, 2024 | finance.yahoo.comJonesTrading Reaffirms Their Hold Rating on TRACON Pharmaceuticals (TCON)March 13, 2024 | markets.businessinsider.comBuy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical TrialsMarch 8, 2024 | markets.businessinsider.comTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateMarch 7, 2024 | finanznachrichten.deTRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | seekingalpha.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finance.yahoo.comTRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateMarch 5, 2024 | globenewswire.comTracon Q4 2023 Earnings PreviewMarch 4, 2024 | msn.comA Preview Of TRACON Pharma's EarningsMarch 4, 2024 | benzinga.comTRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024February 28, 2024 | globenewswire.comTRACON Pharmaceuticals, Inc. (TCON)February 13, 2024 | finance.yahoo.comTRACON Pharma Stock (NASDAQ:TCON), Guidance and ForecastDecember 23, 2023 | benzinga.comBuy Rating for TRACON Pharmaceuticals on Envafolimab’s Promising Trial Outcomes and Strong Market PotentialDecember 21, 2023 | markets.businessinsider.comTCON TRACON Pharmaceuticals, Inc.November 25, 2023 | seekingalpha.comWhy Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?November 21, 2023 | msn.comAnalysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON), Anavex Life Sciences (AVXL) and Genmab (GMAB)November 21, 2023 | markets.businessinsider.comTRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront PaymentNovember 20, 2023 | finance.yahoo.comPromising Financial and Clinical Prospects Bolster Buy Rating for TRACON PharmaceuticalsNovember 15, 2023 | markets.businessinsider.comTRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call TranscriptNovember 12, 2023 | finance.yahoo.comTRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 10, 2023 | finanznachrichten.deTRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 9, 2023 | finance.yahoo.comTRACON Pharmaceuticals (TCON) Price Target Increased by 21.88% to 6.63November 1, 2023 | msn.comTRACON Pharmaceuticals Inc TCONNovember 1, 2023 | morningstar.comTRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023October 31, 2023 | finance.yahoo.comWhy Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketOctober 27, 2023 | benzinga.comTRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as PlannedSeptember 18, 2023 | finance.yahoo.com7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot PoleSeptember 2, 2023 | finance.yahoo.comJonesTrading Downgrades TRACON Pharmaceuticals (TCON)August 22, 2023 | msn.com Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address AI Expert Reveals New Pick (Ad)Why You Shouldn't Pour All Your Money Into Nvidia Jeff Brown, who predicted Nvidia's rise, warns against putting all your money into Nvidia now. His latest AI forecast offers smarter ways to potentially multiply your gains. Get his full forecast here. TCON Media Mentions By Week TCON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TCON News Sentiment▼0.460.72▲Average Medical News Sentiment TCON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TCON Articles This Week▼20▲TCON Articles Average Week Get TRACON Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TCON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: 180 Life Sciences News Today Cyclacel Pharmaceuticals News Today Virpax Pharmaceuticals News Today Revelation Biosciences News Today ASLAN Pharmaceuticals News Today Panbela Therapeutics News Today GRI Bio News Today Altamira Therapeutics News Today PaxMedica News Today Psyence Biomedical News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TCON) was last updated on 10/10/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredAI Expert Reveals New PickWhy You Shouldn't Pour All Your Money Into Nvidia Jeff Brown, who predicted Nvidia's rise, warns against pu...Brownstone Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRACON Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
